Acarix AB (publ)
Acarix AB (publ), a medical device company, develops solutions for rapid AI-based coronary artery disease rule-out. The company offers CADScor System, a point-of-care diagnostic aid that uses sensitive acoustics and advanced computational processing to analyze the patient's coronary blood flow. It sells its products in the Nordic countries, the United Kingdom, Germany, Switzerland, Austria, Mauri… Read more
Acarix AB (publ) (ACIXF) - Total Liabilities
Latest total liabilities as of September 2025: $3.62 Million USD
Based on the latest financial reports, Acarix AB (publ) (ACIXF) has total liabilities worth $3.62 Million USD as of September 2025.
Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.
Acarix AB (publ) - Total Liabilities Trend (2014–2024)
This chart illustrates how Acarix AB (publ)'s total liabilities have evolved over time, based on quarterly financial data. Explore and compare other companies by total liabilities.
Acarix AB (publ) Competitors by Total Liabilities
The table below lists competitors of Acarix AB (publ) ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
ELUON Corporation
KQ:065440
|
Korea | ₩24.94 Billion |
|
ENGIE Eps S.A
F:8XE
|
Germany | €300.64 Million |
|
Pacific Century Premium Developments Limited
PINK:PCPDF
|
USA | $11.31 Billion |
|
TWi Biotechnology, Inc.
TWO:6610
|
Taiwan | NT$124.72 Million |
|
Mohenz.Co.Ltd
KQ:006920
|
Korea | ₩19.16 Billion |
|
Benfica
LS:SLBEN
|
Portugal | €483.36 Million |
|
Wheels Up Experience Inc
NYSE:UP
|
USA | $1.35 Billion |
|
FSA Group Ltd
AU:FSA
|
Australia | AU$949.95 Million |
Liability Composition Analysis (2014–2024)
This chart breaks down Acarix AB (publ)'s total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 9.47 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 0.09 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.09 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Acarix AB (publ)'s debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Acarix AB (publ) (2014–2024)
The table below shows the annual total liabilities of Acarix AB (publ) from 2014 to 2024.
| Year | Total Liabilities | Change |
|---|---|---|
| 2024-12-31 | $5.06 Million | -53.96% |
| 2023-12-31 | $11.00 Million | -37.70% |
| 2022-12-31 | $17.66 Million | -2.22% |
| 2021-12-31 | $18.06 Million | +131.14% |
| 2020-12-31 | $7.81 Million | +22.43% |
| 2019-12-31 | $6.38 Million | +672.63% |
| 2018-12-31 | $825.88K | +32.40% |
| 2017-12-31 | $623.78K | -68.03% |
| 2016-12-31 | $1.95 Million | +378.35% |
| 2015-12-31 | $407.86K | +0.96% |
| 2014-12-31 | $404.00K | -- |